Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
종목 코드 PEN
회사 이름Penumbra Inc
상장일Sep 18, 2015
CEOMr. Adam Elsesser, J.D.
직원 수4500
유형Ordinary Share
회계 연도 종료Sep 18
주소One Penumbra Place
도시ALAMEDA
증권 거래소NYSE Consolidated
국가United States of America
우편 번호94502
전화15109952486
웹사이트https://www.penumbrainc.com/
종목 코드 PEN
상장일Sep 18, 2015
CEOMr. Adam Elsesser, J.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음